← Explorer/Network

Melanocortin Signalling Mechanisms

Eves P, Haycock J2010Advances in experimental medicine and biologyReview
10.1007/978-1-4419-6354-3_2PubMedFree full text
Endocrine (ADH/ACTH/MSH)

Abstract

The melanocortin family are a series of very potent neuropeptides that derive from a parent propopiomelanocortin molecule (POMC). They are expressed predominantly in the brain, specifically the pituitary gland and also in the central nervous system. Interestingly, recent research also suggests the existence of regulatory functions outside of the brain, in a wide range of peripheral tissues. Several important melanocortin peptides with differing functions are created by the tissue-specific proteolytic cleavage of POMC, generating peptides including ACTH and α-MSH. For many years the major recognised function of α-MSH was an ability to stimulate melanocyte cells of the skin to pigment. However, a number of parallel functions unrelated to melanogenesis have been described in the literature for several years. A more complete understanding of this work arose after the discovery and cloning of the melanocortin receptors in 1992, which lead to the recognition of many wider roles of the melanocortin peptides. The knowledge of the tissue in which a given receptor subtype was expressed could now be combined with functional downstream studies. From these studies, we know that α-MSH has a very significant role in controlling inflammation and immunomodulation, with other roles including control over energy homeostasis and exocrine secretion, an ability to trigger erectile functions and the control of sexual behaviour. This chapter will briefly review the melanocortin system and melanocortin receptors, with a focus on the key signalling mechanisms of α-MSH and how these link receptors through to function.

Cited By (1)

  • The melanocortin system in control of inflammationThe Scientific World JOURNAL · 2010

References (9)

  • Targeting melanocortin receptors as a novel strategy to control inflammationPharmacological Reviews · 2004
  • Anti-inflammatory actions of the neuroimmunomodulator α-MSHImmunology Today · 1997
  • α-Melanocyte Stimulating Hormone Prevents Lipopolysaccharide-Induced Vasculitis by Down-Regulating Endothelial Cell Adhesion Molecule ExpressionEndocrinology · 2003
  • Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agentsThe Journal of Immunology · 1998
  • α-Melanocyte-stimulating Hormone Reduces Impact of Proinflammatory Cytokine and Peroxide-generated Oxidative Stress on Keratinocyte and Melanoma Cell LinesJournal of Biological Chemistry · 2000

Related Papers

  • Pro-resolving and anti-arthritic properties of the MC1 selective agonist PL8177Frontiers in Immunology · 2022 · 1 shared tag
  • Probing the VIPR2 Microduplication Linkage to Schizophrenia in Animal and Cellular ModelsFrontiers in Neuroscience · 2021 · 1 shared tag
  • CGRP sensory neurons promote tissue healing via neutrophils and macrophagesNature · 2024 · 1 shared tag
  • Invited review: Mechanisms of hypophagia during diseaseJournal of Dairy Science · 2021 · 1 shared tag
  • Considering traditional Chinese medicine as adjunct therapy in the management of chronic constipation by regulating intestinal floraBioScience Trends · 2024 · 1 shared tag
  • Lipid-Induced Insulin Resistance Mechanisms: The Link to Inflammation and Type 2 Diabetes.2021 · 1 shared tag
Modulation of ICAM-1 expression by α-MSH in human melanoma cells and melanocytes
Journal of Cellular Physiology · 1998
  • Targeting melanocortin receptors as potential novel therapeuticsPharmacology & Therapeutics · 2006
  • New aspects on the melanocortins and their receptorsPharmacological Research · 2000
  • Effect of Alpha- and Beta-Melanocyte Stimulating Hormones on the Skin Colour of ManNature · 1961